VERAVANTI INC.
Optical pH (OpH) device combining fluorescence imaging with pH mapping to detect early-stage dental caries
- Sector
- Medtech
- Headquarters
- BOTHELL, WA
- Founded
- 2013
- Latest Form D
- $28.3M, Mar 2025
- Total capital
- $32.1M
- Federal grants
- $3.2M
- 6 awards · 2017–2024
- Rank in peer group#12 of 542
- Private capital raised
- $28.9M
- 2 Form D · last Mar 2025
- 20 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 2 pending · first 2021
- Rank in peer group#60 of 542
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$28.3M
- Federal grantHealth and Human S · Phase I · Development of Quantitative In Vivo Imaging of Oral Biofilm pH to Allow Prevention of Enamel Demineralization$309K
- Federal grantHealth and Human S · Phase II · Endoscope development for the clinical use of near infrared fluorescence molecular probes in the GI tract$1M
- Federal grantHealth and Human S · Phase II · Endoscope development for the clinical use of near infrared fluorescence molecular probes in the GI tract$993K
- Federal grantHealth and Human S · Phase I · Optical visualization to efficiently guide coronary intervention of chronic total occlusions.$286K
- Private capital raisedForm D · SEC · 1st filing$540K
- Federal grantHealth and Human S · Phase I · " Channel Multimodal Ultrathin Flexible SFE for cancer diagnosis and therapy"$300K
Show 1 earlier federal award
- Federal grantHealth and Human S · Phase I · "4-Channel Multimodal Ultrathin-Flexible SFE for cancer diagnosis and therapy"$300K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
1month
from VERAVANTI INC.’s first federal award to its first private round.
- First federal award · May 2017
- Health and Human S · $300K
- First Form D · May 2017
- $540K · 1st Form D
- Awards before first raise
- 2 awards
An association in public records, not a cause or a prediction.
Standing among 542 peers
Line = medianMedtech · Device
- Federal grants#12 · top 2%
- Granted patents#60 · top 11%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Gerald McMorrowResearcherExecutive Officer, Director, PromoterLinked by 3 patents · $3.2M in grants as PI
- David AuthDirectorNamed in SEC Form D filings
- David GoeslingExecutive OfficerNamed in SEC Form D filings
- Eric SiebelExecutive OfficerNamed in SEC Form D filings
- Frederic MollDirectorNamed in SEC Form D filings
- Juan VegarraExecutive OfficerNamed in SEC Form D filings
Show all 9 people
- Luis SavastanoExecutive OfficerNamed in SEC Form D filings
- Michael MoyerDirectorNamed in SEC Form D filings
- Russell GarrisonExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 5- GrantedSynchronizing An Optical Coherence Tomography SystemUSPTOUS 12,385,733
- GrantedForward Looking Rgb/optical Coherence Tomography Duplex ImagerUSPTOUS 11,530,910
- GrantedForward Looking Rgb/optical Coherence Tomography Duplex ImagerUSPTOUS 11,047,671
Show all 5 patent records
- Synchronizing An Optical Coherence Tomography SystemAug 12, 2025 · US 12,385,733Granted
- Forward Looking Rgb/optical Coherence Tomography Duplex ImagerDec 20, 2022 · US 11,530,910Granted
- Forward Looking Rgb/optical Coherence Tomography Duplex ImagerJun 29, 2021 · US 11,047,671Granted
- Synchronizing An Optical Coherence Tomography SystemApplication PCTUS2023084141Pending
- Forward Looking Rgb/optical Coherence Tomography Duplex ImagerApplication PCTUS2021014972Pending
Related companies, and why
- SHAPE MEDICAL SYSTEMS, INC.Similar federal contract value in Medtech · null in contracts
- Enspectra Health, Inc.Similar federal contract value in Medtech · null in contracts
- Novab, Inc.Similar federal contract value in Medtech · null in contracts
- Intabio, Inc.Similar federal contract value in Medtech · null in contracts
- Injectsense, Inc.Similar federal contract value in Medtech · null in contracts
- ASTRIN BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .